Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Finasteride negatively affects fish reproduction and gonadal development.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Certain drugs change freshwater snail shells to a "banana" shape.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Compounds from the plant Mammea siamensis may help treat hair loss.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Some common medications can harm male fertility, but many effects can be reversed.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.